SPY468.28+9.49 2.07%
DIA357.74+4.92 1.39%
IXIC15,686.92+461.76 3.03%

HC Wainwright & Co. Maintains Buy on HOOKIPA Pharma, Lowers Price Target to $15

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and lowers the price target from $21 to $15.

Benzinga · 11/11/2021 06:24
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and lowers the price target from $21 to $15.